🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "targeted steps to deal with household expense challenges" in the upcoming financial statement.

Speaking to media outlets, she emphasized that reducing inflation is a collective task of both the administration and the central bank.

The UK's price growth is forecast to be the highest among the Group of Seven industrialized countries this calendar year and next.

Possible Energy Bill Interventions

Sources suggest the government could intervene to lower energy bills, for example by cutting the present 5% level of VAT charged on energy.

A further approach is to reduce some of the government charges presently added to bills.

Budgetary Limitations and Expert Predictions

The administration will receive the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for such actions.

The expectation from most economists is that Reeves will have to announce tax increases or expenditure reductions in order to fulfill her declared borrowing rules.

Earlier on the same day, analysis showed there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a collective job between the central bank and the government to bear down further on some of the drivers of inflation," Reeves told reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and Global Issues

While much of the attention has been on likely tax increases, the Treasury chief said the most recent information from the fiscal watchdog had not changed her commitment to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing international and commercial concerns for the fiscal tax moves, likely to be focused on those "with the broadest shoulders."

Global Economic Disputes

Addressing concerns about the United Kingdom's economic relations with China she said: "Our national security always take priority."

Recent declaration by Chinese authorities to strengthen export controls on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an additional 100% tariff on imports from China, raising the risk of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the US offer to participate in its dispute with China, the Chancellor said she was "very concerned" by China's actions and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "damaging for the global economy and creates further obstacles."

"In my view there are fields where we need to address China, but there are also significant chances to trade with Chinese markets, including financial services and other areas of the economy. We've got to get that equilibrium appropriate."

The chancellor also stated she was working with international partners "on our own essential resources plan, so that we are more independent."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service pays for drugs could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or canceling operations in the United Kingdom, with some blaming the low prices they are receiving.

Last month, the government science advisor said the cost the health service spends on drugs would need to rise to stop companies and drug research funding leaving the UK.

Reeves stated to media: "It has been observed because of the payment system, that drug testing, innovative medicines have not been available in the United Kingdom in the extent that they are in other continental states."

"We want to make sure that individuals getting treatment from the NHS are able to access the finest life-saving drugs in the world. And so we are reviewing this situation, and... looking to secure increased capital into Britain."